Green Point’s research and development partnerships coupled with its commitment to serve the entire hemp supply chain catalyzed the development of two consumer cannabinoid brands, Satividol and GramCo. Satividol emerged in 2019 as a prominent Florida-based CBD brand engaged in clinical research trials in partnership with Florida State University. The GramCo was founded in 2021, driven by customer demand for novel cannabinoids beyond CBD. Both brands prioritize quality products and customer experiences and have earned the loyalty of customers across America.
GramCo provides quality, consistent, and wide-ranging Delta 8 products to fill any need at any time. GramCo was formed in early 2021 by hemp farmers and processors with decades of combined experience in the hemp and cannabis industry. Whether farming hemp in Florida, Colorado, New York or Oregon, or extracting and refining hemp in Florida, South Carolina or Colorado, we have seen and experienced most everything you can in this industry.
This experience farming and processing hemp has allowed us to refine our Delta 8 THC products to the highest of standards, while maintaining consistent relationships with suppliers to ensure our customers receive the best Delta 8 vapes, carts, gummies, pre-rolls, coffee, and more. Additionally, you can be sure all our products are tested so the label matches the cannabinoid potency.
It’s not just about high-quality ingredients. It’s about being involved in every step of the way. Satividol focuses on preserving the unique characteristics of our products at every step of the supply chain to provide our customers with clean, quality ingredients straight from the source.
Satividol is created in a cGMP facility with the highest quality CBD available. We test everything for purity to ensure that no harmful chemicals are present in the final product, to give you results you can trust.
We are cannabinoid-agnostic and aim to serve the needs of the industry through our suite of products. Click below for a few of our top sellers.
Sign up with your email address to receive news and updates.
